| Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET) FG Fernandez, JA Drebin, DC Linehan, F Dehdashti, BA Siegel, ... Annals of surgery 240 (3), 438-450, 2004 | 790 | 2004 |
| Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancer J Bradley, WL Thorstad, S Mutic, TR Miller, F Dehdashti, BA Siegel, ... International Journal of Radiation Oncology* Biology* Physics 59 (1), 78-86, 2004 | 766 | 2004 |
| A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy KSC Chao, WR Bosch, S Mutic, JS Lewis, F Dehdashti, MA Mintun, ... International Journal of Radiation Oncology* Biology* Physics 49 (4), 1171-1182, 2001 | 596 | 2001 |
| Lymph node staging by positron emission tomography in patients with carcinoma of the cervix PW Grigsby, BA Siegel, F Dehdashti Journal of Clinical Oncology 19 (17), 3745-3749, 2001 | 580 | 2001 |
| Metabolic flare: indicator of hormone responsiveness in advanced breast cancer JE Mortimer, F Dehdashti, BA Siegel, K Trinkaus, JA Katzenellenbogen, ... Journal of Clinical Oncology 19 (11), 2797-2803, 2001 | 502 | 2001 |
| FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features KL Berger, SA Nicholson, F Dehdashti, BA Siegel American Journal of Roentgenology 174 (4), 1005-1008, 2000 | 441 | 2000 |
| In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM F Dehdashti, MA Mintun, JS Lewis, J Bradley, R Govindan, R Laforest, ... European journal of nuclear medicine and molecular imaging 30, 844-850, 2003 | 432 | 2003 |
| Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response—a preliminary report F Dehdashti, PW Grigsby, MA Mintun, JS Lewis, BA Siegel, MJ Welch International Journal of Radiation Oncology* Biology* Physics 55 (5), 1233-1238, 2003 | 432 | 2003 |
| Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum MH Whiteford, HM Whiteford, LF Yee, OA Ogunbiyi, F Dehdashti, ... Diseases of the colon & rectum 43 (6), 759-767, 2000 | 417 | 2000 |
| Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays F Dehdashti, JE Mortimer, BA Siegel, LK Griffeth, TJ Bonasera, ... Journal of Nuclear Medicine 36 (10), 1766-1774, 1995 | 404 | 1995 |
| Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. FL Flanagan, F Dehdashti, BA Siegel, DD Trask, SR Sundaresan, ... AJR. American journal of roentgenology 168 (2), 417-424, 1997 | 400 | 1997 |
| 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse N Oyama, TR Miller, F Dehdashti, BA Siegel, KC Fischer, JM Michalski, ... Journal of Nuclear Medicine 44 (4), 549-555, 2003 | 397 | 2003 |
| Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography MS Cohen, N Arslan, F Dehdashti, GM Doherty, TC Lairmore, LM Brunt, ... Surgery 130 (6), 941-946, 2001 | 390 | 2001 |
| 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors CJ Anderson, F Dehdashti, PD Cutler, SW Schwarz, R Laforest, LA Bass, ... Journal of Nuclear Medicine 42 (2), 213-221, 2001 | 377 | 2001 |
| Positron emission tomographic assessment of” metabolic flare” to predict response of metastatic breast cancer to antiestrogen therapy F Dehdashti, FL Flanagan, JE Mortimer, JA Katzenellenbogen, MJ Welch, ... European journal of nuclear medicine 26, 51-56, 1999 | 356 | 1999 |
| 18f-fdg pet definition of gross tumor volume for radiotherapy of non–small cell lung cancer: Is a single standardized uptake value threshold approach appropriate? KJ Biehl, FM Kong, F Dehdashti, JY Jin, S Mutic, I El Naqa, BA Siegel, ... Journal of Nuclear Medicine 47 (11), 1808-1812, 2006 | 354 | 2006 |
| The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival EA Kidd, BA Siegel, F Dehdashti, PW Grigsby Cancer 110 (8), 1738-1744, 2007 | 349 | 2007 |
| Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma JK Schwarz, BA Siegel, F Dehdashti, PW Grigsby Jama 298 (19), 2289-2295, 2007 | 345 | 2007 |
| Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis EA Kidd, BA Siegel, F Dehdashti, JS Rader, DG Mutch, MA Powell, ... Journal of clinical oncology 28 (12), 2108-2113, 2010 | 336 | 2010 |
| Lower-dose vs high-dose oral estradiol therapy of hormone receptor–positive, aromatase inhibitor–resistant advanced breast cancer: A phase 2 randomized study MJ Ellis, F Gao, F Dehdashti, DB Jeffe, PK Marcom, LA Carey, MN Dickler, ... Jama 302 (7), 774-780, 2009 | 335 | 2009 |
